VanEck Pharmaceutical ETF
PPH
#1267
ETF rank
โ‚ฌ0.87 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
88,37ย โ‚ฌ
Share price
0.57%
Change (1 day)
21.69%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.36%